Brief: Omega Therapeutics Presents New Preclinical Data On Potential Hepatocellular Carcinoma Treatment At Conference
30/06/2022 12:08
June 30 (Reuters) - Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS PRESENTS NEW PRECLINICAL DATA
SUPPORTING THE
FIRST EPIGENOMIC CONTROLLER, OTX-2002, AS A POTENTIAL
THERAPEUTIC APPROACH IN HEPATOCELLULAR CARCINOMA AT THE ESMO
2022 WORLD CONGRESS ON GASTROINTESTINAL CANCER
Source text for Eikon: ID:nPn9SslLGa
Further company coverage: OMGA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence